(Q42920572)

11 November 2017

Asiatic acid preserves beta cell mass and mitigates hyperglycemia in streptozocin-induced diabetic rats (English)

1 reference

11 November 2017

1 reference

Jun Liu

1

1 reference

11 November 2017

Ting He

2

1 reference

11 November 2017

Qian Lu

3

1 reference

11 November 2017

Jing Shang

4

1 reference

11 November 2017

Hongbin Sun

5

1 reference

11 November 2017

Luyong Zhang

6

1 reference

11 November 2017

language of work or name

1 reference

1 September 2010

1 reference

Diabetes - Metabolism: Research and Reviews

11 November 2017

1 reference

11 November 2017

26

1 reference

11 November 2017

6

1 reference

11 November 2017

448-454

1 reference

Diabetes in America: epidemiology and scope of the problem

11 November 2017

1 reference

Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes

21 January 2018

1 reference

7 January 2021

Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes

1 reference

7 January 2021

Beta-cell replacement therapy (pancreas and islet transplantation) for treatment of diabetes mellitus: an integrated approach

1 reference

7 January 2021

Stem cells for the treatment of diabetes.

1 reference

7 January 2021

Stem/Progenitor cell sources of insulin-producing cells for the treatment of diabetes

1 reference

7 January 2021

Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes

1 reference

7 January 2021

Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.

1 reference

7 January 2021

Impact of sitagliptin on markers of beta-cell function: a meta-analysis

1 reference

7 January 2021

Synthesis of glucoconjugates of oleanolic acid as inhibitors of glycogen phosphorylase.

1 reference

7 January 2021

Synthesis and biological evaluation of asiatic acid derivatives as inhibitors of glycogen phosphorylases

1 reference

7 January 2021

Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies

1 reference

7 January 2021

Efficient access to 2-isobetulinic acid, 2-isooleanolic acid, and 2-isoursolic acid

1 reference

7 January 2021

Practical synthesis of bredemolic acid, a natural inhibitor of glycogen phosphorylase

1 reference

7 January 2021

Pentacyclic triterpenes. Part 5: synthesis and SAR study of corosolic acid derivatives as inhibitors of glycogen phosphorylases

1 reference

7 January 2021

Maslinic acid reduces blood glucose in KK-Ay mice

1 reference

7 January 2021

Pentacyclic triterpenes. Part 2: Synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors

1 reference

7 January 2021

Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase

1 reference

7 January 2021

Centella asiatica accelerates nerve regeneration upon oral administration and contains multiple active fractions increasing neurite elongation in-vitro

1 reference

7 January 2021

Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice

1 reference

7 January 2021

Diabetes Treatment — Bridging the Divide

1 reference

7 January 2021

Diabetes. Islet cell transplantation

1 reference

7 January 2021

Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.1101

1 reference

11 November 2017

1 reference